Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Technology Sector · ProShares

Biotechnology Ultrasector Profund BIOTECHNOLOGY ULTRASECTOR PROFUND SERVICE CLASS (BIPSX)

Ticker BIPSX · Since 2000-06-19 · · Holdings as of Jul 31, 2026

Expense ratio
2.52%$252/yr per $10k
5-yr return
+5.0%annualized
1-yr return
−6.2%as of Dec 2024
Net assets
$118.7Mall share classes
Holdings
159

Bottom line

Is BIPSX a good fund? The bottom line

BIPSX is a share class of Biotechnology Ultrasector Profund, a managed technology sector mutual fund from ProShares.

Annual fees run 2.52% — about $252 a year on every $10,000 invested, more expensive than 98% of technology sector funds we track.

It returned −6.2% over one year, +5.0% a year over five years, +3.4% a year over ten (as of Dec 31, 2024, per its prospectus).

With $119 million in net assets and 159 holdings, its largest position is N/a (6.7%) and the top 10 make up 30.5% of the portfolio.

What to watch

  • Expensive for its category (2.52%)
  • 12b-1 marketing fee of 1% a year

Updated Nov 19, 2026

What BIPSX invests in

Biotechnology UltraSector ProFund (the Fund) seeks daily investment results, before fees and expenses, that correspond to one and one-half times (1.5x) of the daily performance of the S&P Biotechnology Select Industry Index (the Index).

The Fund invests in financial instruments that ProFund Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The Index is designed to measure the performance of biotechnology companies included in the S&P Total Market Index. The S&P Total Market Index is designed to track the broad equity market listed and domiciled in the U.S. The Index includes companies in the biotechnology sub-industry according to the Global Industry Classification Standard (GICS). These companies are then weighted using an equal weight methodology with liquidity adjustments. The Indexs composition and the assigned weights are reevaluated every September with additional weight adjustments in March, June, and December. The Index is constructed and maintained by S&P Dow Jones Indices LLC. More information about the Index can be found using the Bloomberg ticker symbol…

From the fund's prospectus (filed Nov 25, 2025).

BIPSX performance

Average annual total returns
1 yr5 yr10 yr
BIPSX−6.2%+5.0%+3.4%
Technology Sector median+24.0%+10.0%+16.7%

Source: Fund prospectus, as of Dec 31, 2024

Full BIPSX performance history →

What BIPSX costs

On a $10,000 investment, BIPSX's 2.52% expense ratio costs about $252 a year. The prospectus estimates $2,856 in total costs over 10 years (assuming 5% annual returns). The median technology sector fund charges 0.75%.

See the full BIPSX fee table →

BIPSX top 10 holdings

#Holding% of fund
1N/a6.70%
2N/a5.15%
3N/a4.12%
4N/a4.12%
5N/a3.16%
6Agpxx2.40%
7Apogee Therapeutics Inc1.29%
8N/a1.24%
9Oruka Therapeutics Inc1.20%
10Dianthus Therapeutics Inc1.12%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 30.5% of the fund. See all top 25 holdings and asset mix →

Alternatives to BIPSX

More funds like BIPSX →

BIPSX FAQ

What is the expense ratio of BIPSX?
BIPSX's expense ratio is 2.52%, which works out to about $252 a year for every $10,000 invested. The prospectus estimates total costs of $2,856 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is BIPSX a good investment?
It depends on your goals, but the data points to: expensive for its category (2.52%); 12b-1 marketing fee of 1% a year. This is general information, not personalized advice.
What does BIPSX hold?
BIPSX's largest holdings are N/a (6.7%), N/a (5.2%), N/a (4.1%), N/a (4.1%), N/a (3.2%). It holds 159 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
What is BIPSX's 5-year return?
BIPSX returned +5.0% a year over the five years ending Dec 31, 2024, and +3.4% a year over ten years. Past performance does not guarantee future results.
Who manages BIPSX?
BIPSX is offered by ProShares through ProFunds.